Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7840662 | 0.97 | EDNRA (0.81) | EDNRAEDNRB | |
| SCHEMBL7831037 | 0.95 | EDNRA (0.79) | EDNRAEDNRB | |
| SCHEMBL7840363 | 0.93 | EDNRA (0.76) | EDNRAEDNRB | |
| SCHEMBL7845546 | 0.91 | EDNRA (0.73) | EDNRAEDNRB | |
| SCHEMBL7838184 | 0.90 | EDNRA (0.75) | EDNRAEDNRB | |
| SCHEMBL8031920 | 0.90 | EDNRA (1.00) | EDNRAEDNRB | |
| SCHEMBL6314844 | 0.90 | EDNRA (0.77) | EDNRAEDNRB | |
| SCHEMBL7845097 | 0.89 | EDNRA (0.73) | EDNRAEDNRB | |
| SCHEMBL7831557 | 0.89 | EDNRA (0.63) | EDNRAEDNRB | |
| SCHEMBL7841187 | 0.89 | EDNRA (0.79) | EDNRAEDNRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0882030-B1 | 2,1,3-BENZOTHIA(OXA)DIAZOLE DERIVATIVES HAVING AN ENDOTHELIN RECEPTOR ANTAGONISTIC EFFECT | MERCK PATENT GMBH (DE) | 2001-09-12 | — | — | EP | disclosed |
| EP-0882030-A1 | 2,1,3-BENZOTHIA(OXA)DIAZOLE DERIVATIVES HAVING AN ENDOTHELIN RECEPTOR ANTAGONISTIC EFFECT | MERCK PATENT GmbH (DE) | 1998-12-09 | — | — | EP | disclosed |
| WO-1998042702-A1 | ENDOTHELIN-RECEPTOR ANTAGONISTS | MERCK PATENT GMBH (DE) | 1998-10-01 | — | — | WO | disclosed |
| WO-1997030982-A1 | 2,1,3-BENZOTHIA(OXA)DIAZOLE DERIVATIVES HAVING AN ENDOTHELIN RECEPTOR ANTAGONISTIC EFFECT | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 1997-08-28 | — | — | WO | disclosed |